New Jersey Res Financials
This page shows New Jersey Res (NJR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cash-backed profits support a steadily larger asset base, but capital spending still outruns internal funding and keeps financing relevant.
Across the last three annual periods, operating cash flow stayed above net income, ending at$466M versus$336M . But with investing outflows still running at$539M -$569M a year, the company is funding growth with internal cash plus regular external capital, not self-financing expansion.
Over the last three annual periods, long-term debt rose from
Liquidity is deliberately lean: cash was only
Financial Health Signals
Scored against utilities for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of New Jersey Res's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
New Jersey Res scores 1.32, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($5.9B) relative to total liabilities ($5.2B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
New Jersey Res passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, New Jersey Res generates $1.39 in operating cash flow ($466.3M OCF vs $335.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
New Jersey Res earns $4.0 in operating income for every $1 of interest expense ($508.9M vs $128.6M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
New Jersey Res generated $1.4B in revenue in fiscal year 2025. This represents an increase of 9.9% from the prior year.
New Jersey Res's EBITDA was $697.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 11.7% from the prior year.
New Jersey Res reported $335.6M in net income in fiscal year 2025. This represents an increase of 15.8% from the prior year.
New Jersey Res earned $3.33 per diluted share (EPS) in fiscal year 2025. This represents an increase of 14.0% from the prior year.
Cash & Balance Sheet
New Jersey Res held $591K in cash against $3.3B in long-term debt as of fiscal year 2025.
New Jersey Res paid $1.82 per share in dividends in fiscal year 2025. This represents an increase of 6.7% from the prior year.
New Jersey Res had 100M shares outstanding in fiscal year 2025. This represents an increase of 1.0% from the prior year.
Margins & Returns
New Jersey Res's operating margin was 37.7% in fiscal year 2025, reflecting core business profitability. This is up 0.4 percentage points from the prior year.
New Jersey Res's net profit margin was 24.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.3 percentage points from the prior year.
New Jersey Res's ROE was 14.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.9 percentage points from the prior year.
Capital Allocation
NJR Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $641.4M+45.5% | $440.9M+134.1% | $188.3M-19.8% | $234.8M-58.7% | $569.2M+58.6% | $359.0M+35.1% | $265.7M+26.6% | $209.9M |
| Cost of Revenue | $274.9M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $299.9M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $301.0M+68.0% | $179.2M+343.6% | $40.4M+3904.4% | -$1.1M-100.4% | $279.9M+47.7% | $189.6M+29.7% | $146.1M+2361.7% | $5.9M |
| Interest Expense | $35.0M-2.0% | $35.7M+17.0% | $30.5M-3.8% | $31.7M-2.6% | $32.5M-4.0% | $33.9M-5.9% | $36.0M+15.5% | $31.2M |
| Income Tax | $66.2M+93.4% | $34.2M+996.6% | $3.1M+160.7% | -$5.1M-108.3% | $61.6M+64.8% | $37.4M+21.4% | $30.8M+1213.9% | -$2.8M |
| Net Income | $218.9M+78.7% | $122.5M+712.7% | $15.1M+200.1% | -$15.1M-107.4% | $204.3M+55.6% | $131.3M+44.1% | $91.1M+887.3% | -$11.6M |
| EPS (Diluted) | $2.16+78.5% | $1.21 | N/A | $-0.15-107.4% | $2.02+54.2% | $1.31 | N/A | $-0.12 |
NJR Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.9B+0.5% | $7.9B+4.3% | $7.6B+4.2% | $7.3B+0.1% | $7.3B+1.0% | $7.2B+3.0% | $7.0B+2.9% | $6.8B |
| Current Assets | $730.3M-6.5% | $781.3M+37.1% | $569.9M+1.3% | $562.3M-17.1% | $678.6M-7.1% | $730.7M+31.8% | $554.6M+3.8% | $534.4M |
| Cash & Equivalents | $125.3M+5047.2% | $2.4M+311.8% | $591K-36.5% | $931K-98.9% | $83.7M+4287.2% | $1.9M+87.6% | $1.0M-95.5% | $22.4M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $5.3B-2.6% | $5.4B+4.8% | $5.2B+6.9% | $4.9B+1.3% | $4.8B-1.9% | $4.9B+2.1% | $4.8B+3.0% | $4.6B |
| Current Liabilities | $777.0M-17.2% | $937.9M+20.1% | $780.9M+5.7% | $739.1M+1.0% | $732.0M-10.6% | $818.7M-7.8% | $887.8M-0.7% | $894.3M |
| Long-Term Debt | $3.3B+0.2% | $3.3B+0.7% | $3.3B+7.6% | $3.0B+1.7% | $3.0B-0.6% | $3.0B+3.8% | $2.9B+3.1% | $2.8B |
| Total Equity | $2.6B+7.1% | $2.5B+3.4% | $2.4B-1.3% | $2.4B-2.2% | $2.5B+7.1% | $2.3B+5.1% | $2.2B+2.7% | $2.1B |
| Retained Earnings | $1.7B+11.2% | $1.5B+5.1% | $1.5B-2.2% | $1.5B-3.9% | $1.5B+11.5% | $1.4B+6.6% | $1.3B+3.7% | $1.3B |
NJR Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $562.6M+2004.9% | $26.7M-67.1% | $81.2M+380.8% | -$28.9M-106.8% | $423.0M+4824.0% | -$9.0M-113.9% | $64.5M+165.6% | $24.3M |
| Capital Expenditures | $196.4M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | $366.2M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$196.1M-9.2% | -$179.5M+31.6% | -$262.3M-70.7% | -$153.7M-15.6% | -$132.9M-589.9% | -$19.3M+89.1% | -$176.5M-12.0% | -$157.6M |
| Financing Cash Flow | -$243.6M-257.4% | $154.8M-14.4% | $180.8M+81.0% | $99.9M+148.0% | -$208.0M-812.7% | $29.2M-67.7% | $90.5M-40.0% | $150.7M |
| Dividends Paid | $47.9M+0.3% | $47.7M+5.6% | $45.2M+0.1% | $45.1M+0.3% | $45.0M+0.6% | $44.8M+7.5% | $41.6M+0.8% | $41.3M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NJR Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 52.2% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 46.9%+6.3pp | 40.6%+19.2pp | 21.4%+21.9pp | -0.4%-49.6pp | 49.2%-3.6pp | 52.8%-2.2pp | 55.0%+52.2pp | 2.8% |
| Net Margin | 34.1%+6.3pp | 27.8%+19.8pp | 8.0%+14.4pp | -6.4%-42.3pp | 35.9%-0.7pp | 36.6%+2.3pp | 34.3%+39.8pp | -5.5% |
| Return on Equity | 8.3%+3.3pp | 5.0%+4.3pp | 0.6%+1.3pp | -0.6%-8.9pp | 8.2%+2.6pp | 5.7%+1.5pp | 4.1%+4.7pp | -0.5% |
| Return on Assets | 2.8%+1.2pp | 1.6%+1.4pp | 0.2%+0.4pp | -0.2%-3.0pp | 2.8%+1.0pp | 1.8%+0.5pp | 1.3%+1.5pp | -0.2% |
| Current Ratio | 0.94+0.1 | 0.83+0.1 | 0.73-0.0 | 0.76-0.2 | 0.93+0.0 | 0.89+0.3 | 0.62+0.0 | 0.60 |
| Debt-to-Equity | 1.24-0.1 | 1.32-0.0 | 1.36+0.1 | 1.25+0.0 | 1.20-0.1 | 1.29-0.0 | 1.310.0 | 1.30 |
| FCF Margin | 63.7% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: The current ratio is below 1.0 (0.73), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is New Jersey Res's annual revenue?
New Jersey Res (NJR) reported $1.4B in total revenue for fiscal year 2025. This represents a 9.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is New Jersey Res's revenue growing?
New Jersey Res (NJR) revenue grew by 9.9% year-over-year, from $1.2B to $1.4B in fiscal year 2025.
Is New Jersey Res profitable?
Yes, New Jersey Res (NJR) reported a net income of $335.6M in fiscal year 2025, with a net profit margin of 24.8%.
What is New Jersey Res's EBITDA?
New Jersey Res (NJR) had EBITDA of $697.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does New Jersey Res have?
As of fiscal year 2025, New Jersey Res (NJR) had $591K in cash and equivalents against $3.3B in long-term debt.
What is New Jersey Res's operating margin?
New Jersey Res (NJR) had an operating margin of 37.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is New Jersey Res's net profit margin?
New Jersey Res (NJR) had a net profit margin of 24.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does New Jersey Res pay dividends?
Yes, New Jersey Res (NJR) paid $1.82 per share in dividends during fiscal year 2025.
What is New Jersey Res's return on equity (ROE)?
New Jersey Res (NJR) has a return on equity of 14.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is New Jersey Res's operating cash flow?
New Jersey Res (NJR) generated $466.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are New Jersey Res's total assets?
New Jersey Res (NJR) had $7.6B in total assets as of fiscal year 2025, including both current and long-term assets.
What is New Jersey Res's current ratio?
New Jersey Res (NJR) had a current ratio of 0.73 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is New Jersey Res's debt-to-equity ratio?
New Jersey Res (NJR) had a debt-to-equity ratio of 1.36 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is New Jersey Res's return on assets (ROA)?
New Jersey Res (NJR) had a return on assets of 4.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is New Jersey Res's Altman Z-Score?
New Jersey Res (NJR) has an Altman Z-Score of 1.32, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is New Jersey Res's Piotroski F-Score?
New Jersey Res (NJR) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are New Jersey Res's earnings high quality?
New Jersey Res (NJR) has an earnings quality ratio of 1.39x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can New Jersey Res cover its interest payments?
New Jersey Res (NJR) has an interest coverage ratio of 4.0x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is New Jersey Res?
New Jersey Res (NJR) scores 58 out of 100 on our Financial Health Score, indicating moderate standing within its utilities peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.